论文信息 - [177Lu]Lu-DOTAGA.Glu.(FAPi)2 Radionuclide Therapy: a New Treatment Option for Patients with Glioblastoma Multiforme - 字舞流文

[177Lu]Lu-DOTAGA.Glu.(FAPi)2 Radionuclide Therapy: a New Treatment Option for Patients with Glioblastoma Multiforme

M. Tripathi | S. Ballal | S. Raju | C. Bal | M. Yadav | F. Roesch | Marcel Martin

[1] M. Assadi,et al. PET tracers in glioblastoma: Toward neurotheranostics as an individualized medicine approach , 2023, Frontiers in Nuclear Medicine.

[2] Xiao Jiang,et al. Performance of 18 F-FAPI PET/CT in assessing glioblastoma before radiotherapy: a pilot study , 2022, BMC Medical Imaging.

[3] F. Marini,et al. Imaging of Fibroblast Activation Protein Alpha Expression in a Preclinical Mouse Model of Glioma Using Positron Emission Tomography , 2020, Molecules.

[4] M. Röhrich,et al. Fibroblast Activation Protein (FAP) specific PET for advanced target volume delineation in Glioblastoma , 2020, Nuklearmedizin.

[5] A. Sedo,et al. Heterogeneity of molecular forms of dipeptidyl peptidase-IV and fibroblast activation protein in human glioblastomas. , 2017, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

[6] Z. Zemanová,et al. Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma , 2016, Tumor Biology.

[7] E. Křepela,et al. Coupled expression of dipeptidyl peptidase-IV and fibroblast activation protein-α in transformed astrocytic cells , 2011, Molecular and Cellular Biochemistry.